Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,088 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study.
Lüscher TF, Pieper M, Tendera M, Vrolix M, Rutsch W, van den Branden F, Gil R, Bischoff KO, Haude M, Fischer D, Meinertz T, Münzel T. Lüscher TF, et al. Among authors: gil r. Eur Heart J. 2009 Jul;30(13):1590-7. doi: 10.1093/eurheartj/ehp151. Epub 2009 May 27. Eur Heart J. 2009. PMID: 19474053 Free PMC article. Clinical Trial.
Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients.
Haude M, Konorza TF, Kalnins U, Erglis A, Saunamäki K, Glogar HD, Grube E, Gil R, Serra A, Richardt HG, Sick P, Erbel R; Heparin-COAted STents in small coronary arteries Trial Investigators. Haude M, et al. Among authors: gil r. Circulation. 2003 Mar 11;107(9):1265-70. doi: 10.1161/01.cir.0000053442.64637.34. Circulation. 2003. PMID: 12628946 Clinical Trial.
Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality.
Witkowski A, Maciejewski P, Wasek W, Malek LA, Niewada M, Kaminski B, Drzewiecki J, Kosmider M, Kubica J, Ruzyllo W, Peruga JZ, Dudek D, Opolski G, Dobrzycki S, Gil RJ; STEMI 2003 Registry Collaborators. Witkowski A, et al. Eur Heart J. 2009 Jul;30(14):1736-43. doi: 10.1093/eurheartj/ehp114. Epub 2009 Apr 17. Eur Heart J. 2009. PMID: 19376786
A randomized comparison of elective high-pressure stenting with balloon angioplasty: six-month angiographic and two-year clinical follow-up. On behalf of AS (Angioplasty or Stent) trial investigators.
Witkowski A, Ruzyłło W, Gil R, Górecka B, Purzycki Z, Kośmider M, Poloński L, Lekston A, Gasior M, Zmudka K, Pieniazek P, Buszman P, Drzewiecki J, Ciećwierz D, Sadowski Z. Witkowski A, et al. Among authors: gil r. Am Heart J. 2000 Aug;140(2):264-71. doi: 10.1067/mhj.2000.107555. Am Heart J. 2000. PMID: 10925341 Clinical Trial.
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
Baber U, Dangas G, Angiolillo DJ, Cohen DJ, Sharma SK, Nicolas J, Briguori C, Cha JY, Collier T, Dudek D, Džavik V, Escaned J, Gil R, Gurbel P, Hamm CW, Henry T, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Marx SO, Mehta S, Moliterno D, Ohman EM, Oldroyd K, Sardella G, Sartori S, Shlofmitz R, Steg PG, Weisz G, Witzenbichler B, Han YL, Pocock S, Gibson CM, Mehran R. Baber U, et al. Among authors: gil r. Eur Heart J. 2020 Oct 1;41(37):3533-3545. doi: 10.1093/eurheartj/ehaa670. Eur Heart J. 2020. PMID: 33085967 Clinical Trial.
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
Stefanini GG, Briguori C, Cao D, Baber U, Sartori S, Zhang Z, Dangas G, Angiolillo DJ, Mehta S, Cohen DJ, Collier T, Dudek D, Escaned J, Gibson CM, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Kunadian V, Moliterno DJ, Ohman EM, Oldroyd KG, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Pocock S, Mehran R. Stefanini GG, et al. Among authors: gil r. Eur Heart J. 2021 Dec 1;42(45):4683-4693. doi: 10.1093/eurheartj/ehab533. Eur Heart J. 2021. PMID: 34423374 Clinical Trial.
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
Escaned J, Cao D, Baber U, Nicolas J, Sartori S, Zhang Z, Dangas G, Angiolillo DJ, Briguori C, Cohen DJ, Collier T, Dudek D, Gibson M, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Kunadian V, Mehta S, Moliterno DJ, Ohman EM, Oldroyd KG, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Pocock S, Mehran R. Escaned J, et al. Among authors: gil r. Eur Heart J. 2021 Dec 1;42(45):4624-4634. doi: 10.1093/eurheartj/ehab702. Eur Heart J. 2021. PMID: 34662382 Clinical Trial.
1,088 results